Order Article Reprints

Roozen GVT, Sukwa N, Chirwa M, White JA, Estrada M, Maier N, Turbyfill KR, Laird RM, Suvarnapunya AE, Sayeh A, et al. Safety, Tolerability, and Immunogenicity of the Invaplex_AR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial. Vaccines. 2025; 13(1):48. https://doi.org/10.3390/vaccines13010048

Roozen, Geert V. T., Nsofwa Sukwa, Masuzyo Chirwa, Jessica A. White, Marcus Estrada, Nicole Maier, Kevin R. Turbyfill, Renee M. Laird, Akamol E. Suvarnapunya, Aicha Sayeh, and et al. 2025. "Safety, Tolerability, and Immunogenicity of the Invaplex_AR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial" Vaccines 13, no. 1: 48. https://doi.org/10.3390/vaccines13010048

Roozen, G. V. T., Sukwa, N., Chirwa, M., White, J. A., Estrada, M., Maier, N., Turbyfill, K. R., Laird, R. M., Suvarnapunya, A. E., Sayeh, A., D’Alessio, F., Marion, C., Pattacini, L., Hoogerwerf, M.-A., Murugan, R., Terrinoni, M., Holmgren, J. R., Sirima, S. B., Houard, S., ... Roestenberg, M. (2025). Safety, Tolerability, and Immunogenicity of the Invaplex_AR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial. Vaccines, 13(1), 48. https://doi.org/10.3390/vaccines13010048